Steve Martin founded CIBA VISION Optics in 1980 and CIBA Vision Ophthalmics (now Novartis Ophthalmics) in 1990.
team grew sales of the combined companies to over $1.2 Billion with more than 6,000 employees.
is a world leader in research, development, manufacture and marketing of soft contact lenses, lens-care products and ophthalmic pharmaceuticals.
markets in nearly 90 countries.
Steve was President of CIBA Vision Corporation USA until 1998.
retirement in June 2001 Steve
acted as a venture opportunity liaison on entrepreneurial life science projects for Swiss giant Novartis.
He continues to help entrepreneurs find venture capital funding through Merritt Capital Services where he is a General Partner.
has successfully negotiated more than 70 licensing and acquisition deals with values ranging from $1 million to $320 million.
Steve's worldwide business contacts include decision makers in organizations such as ALZA
, Bank of America Ventures
(now Scale Venture Partners), Bausch & Lomb
, Cordova Ventures
, Domain Associates
, Essex Woodlands Health Ventures
, The FDA
, Frazier Healthcare Ventures
, InterSouth Partners
, Johnson & Johnson
, MPM Capital
, The Nobel Foundation
, Noro-Moseley Partners
, Polaris Ventures
, and Solvay Pharmaceuticals
He has served on the board of directors for numerous public and private companies.
Currently, he is on the board of La Jolla Pharmaceutical Company (LJPC-NASDAQ), NeoVista, Inc. (private) and OcuCure Therapeutics, Inc. (private).
Steve also is an advisor to the CEOs of QSpex, Encompass Pharmaceutical Services, Apeliotus Technologies, and Visioneering.
Steve is a graduate of Wake Forest University and attended the Woodrow Wilson College of Law.
He served as a Captain in the United States Marine Corps.
holds six U.S. Patents issued for his
inventions and a number of European Patents.
wife Judy now live in the North Georgia Mountains.